| Literature DB >> 27498118 |
Abstract
Spontaneous rib fracture after treatment for primary breast cancer is not uncommon. Although metastatic disease accounts for about 30% of spontaneous rib fractures and should constitute the first line of diagnostic investigation, other possible contributors include primary osteoporosis or secondary osteoporosis resulting from cancer treatments. Chemotherapy-induced menopause, aromatase inhibitors, radiation therapy, and long-term bisphosphonate use can all contribute to bone fragility, including spontaneous rib fractures in the latter 3. Drawing on recent breast cancer practice guidelines as well as population-based studies of fracture risk for women with a history of breast cancer and systematic reviews, this Perspective will provide an update on recent developments in understanding how to differentiate the possible reasons for non-traumatic rib fracture in women treated for breast cancer. In addition to describing the various possible causes of spontaneous rib fracture, the recommended medical and imaging procedures for differentiating among the potential causes will be presented.Entities:
Keywords: Aromatase inhibitors; Bone fragility; Differential diagnosis; Metastasis; Radiation fibrosis
Mesh:
Substances:
Year: 2016 PMID: 27498118 DOI: 10.1016/j.clbc.2016.07.001
Source DB: PubMed Journal: Clin Breast Cancer ISSN: 1526-8209 Impact factor: 3.225